causal

Antibiotic development lacks commercial incentive

The failure to develop new antibiotics is not due to a lack of scientific tools but to a lack of commercial incentive, so infection mortality is rising, and policy must reimburse these efforts or the innovation engine stalls.

causalpending

Speaker

Tal

Evidence Quote

“The likelihood of dying from significant infections continues to go up and it's not a lack of scientific tools to understand bacteria”

Source

Bridging Science, Medicine, and Returns— Invest Like the Best
Created: 11/19/2026, 4:01:33 PM

Your notes

Loading notes...